Takeda Pharmaceutical
TAK
#423
Rank
ยฃ36.71 B
Marketcap
ยฃ11.62
Share price
-0.59%
Change (1 day)
7.34%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2024 (TTM): ยฃ23.39 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is ยฃ23.14 Billion. an increase over the revenue in the year 2023 that were of ยฃ23.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ23.88 B3.68%
2023 ยฃ23.03 B-5.83%
2022 ยฃ24.46 B6.68%
2021 ยฃ22.93 B3.58%
2020 ยฃ22.13 B-2.26%
2019 ยฃ22.65 B78.07%
2018 ยฃ12.72 B8.1%
2017 ยฃ11.76 B-9.3%
2016 ยฃ12.97 B26.76%
2015 ยฃ10.23 B-1.04%
2014 ยฃ10.34 B2.3%
2013 ยฃ10.10 B-15.13%
2012 ยฃ11.91 B0.02%
2011 ยฃ11.90 B11.96%
2010 ยฃ10.63 B10.89%
2009 ยฃ9.59 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ68.58 B 196.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.03 B 60.01%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ49.13 B 112.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ39.93 B 72.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ1.77 B-92.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.85 B-87.65%๐Ÿ‡ฎ๐Ÿ‡ณ India
ยฃ25.80 B 11.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.02 B 34.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ49.54 B 114.09%๐Ÿ‡บ๐Ÿ‡ธ USA